Acute pancreatitis and hyperamylasemia in renal homograft recipients
- PMID: 4557978
- PMCID: PMC2964057
- DOI: 10.1001/archsurg.1972.04180080021004
Acute pancreatitis and hyperamylasemia in renal homograft recipients
Abstract
In a series of 301 renal homograft recipients, 17 (5.6%) had acute pancreatitis at some time after transplantation. Eleven of these patients died, for a mortality of 64.7%. In each instance, pancreatitis was a major factor in a complex chain of lethal events to which immunosuppression invariably contributed. An additional 43 patients (14.3%) developed asymptomatic hyperamylasemia after transplantation and, undoubtedly, some of these recipients also had pancreatitis. The factors causing pancreatitis in the renal transplantation patient include uremia, hyperparathyroidism, pancreatic injury by drugs, infections resulting from chronic immunosuppression, gallstones, and operative trauma to the pancreas. In cases of preexisting pancreatitis, transplantation is not necessarily precluded, but efforts should be made to find a specific cause of the pancreatitis and take corrective measures, such as biliary tract surgery or parathyroidectomy if indicated, in advance of transplantation.
Figures




Similar articles
-
Pancreatitis in renal transplantation.Ann Surg. 1970 Feb;171(2):309-14. doi: 10.1097/00000658-197002000-00022. Ann Surg. 1970. PMID: 4905129 Free PMC article. No abstract available.
-
Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine.Am J Surg. 1987 Nov;154(5):487-9. doi: 10.1016/0002-9610(87)90260-1. Am J Surg. 1987. PMID: 2445214 Clinical Trial.
-
Hyperamylasemia in kidney transplant recipients.Transplant Proc. 1996 Jun;28(3):1476-7. Transplant Proc. 1996. PMID: 8658748 Clinical Trial. No abstract available.
-
The use of a peptidase inhibitor in the treatment of acute pancreatitis.Med J Aust. 1969 Jun 21;1(25):1284-5. doi: 10.5694/j.1326-5377.1969.tb62351.x. Med J Aust. 1969. PMID: 4894558 Review. No abstract available.
-
Pancreatitis and hyperparathyroidism.Br J Surg. 1988 Feb;75(2):158-60. doi: 10.1002/bjs.1800750224. Br J Surg. 1988. PMID: 3280087 Review.
Cited by
-
Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient.J Nephropharmacol. 2015 Feb 18;4(2):72-74. eCollection 2015. J Nephropharmacol. 2015. PMID: 28197482 Free PMC article.
-
Management of severe pancreatitis in renal transplant recipients.Ann Surg. 1997 Feb;225(2):217-22. doi: 10.1097/00000658-199702000-00010. Ann Surg. 1997. PMID: 9065299 Free PMC article.
-
Acute pancreatitis following renal allotransplantation. A lethal complication.Am J Dig Dis. 1978 Jun;23(6):541-4. doi: 10.1007/BF01072698. Am J Dig Dis. 1978. PMID: 354374
-
Serum calcium as an early indicator for surgical treatment of hyperparathyroidism after renal transplantation.World J Surg. 1986 Aug;10(4):661-7. doi: 10.1007/BF01655550. World J Surg. 1986. PMID: 3529651 No abstract available.
-
Elective and emergency surgery in renal transplant patients.Ann Surg. 1976 Mar;183(3):266-70. doi: 10.1097/00000658-197603000-00009. Ann Surg. 1976. PMID: 769711 Free PMC article.
References
-
- Hill RB, Jr, Dahrling BE, II, Starzl TE, et al. Death after transplantation. An analysis of sixty cases. Amer J Med. 1967;42:327–334. - PubMed
-
- Starzl TE. Experience in Renal Transplantation. Philadelphia: WB Saunders Co; 1964.
-
- Tilney NL, Collins JJ, Jr, Wilson RE. Hemorrhagic pancreatitis. A fatal complication of renal transplantation. New Eng J Med. 1966;274:1051–1057. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources